Insight Molecular Diagnostics Inc.
IMDX
$3.41
$0.041.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 162.39% | 456.27% | -8.44% | -76.36% | -48.28% |
| Total Receivables | 502.35% | 2,098.76% | 233.26% | -88.89% | -95.05% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 126.89% | 68.03% | 27.68% | -6.70% | -49.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 100.72% | 160.43% | -83.25% |
| Total Current Assets | 169.28% | 454.90% | 9.92% | -71.67% | -52.50% |
|
|
|||||
| Total Current Assets | 169.28% | 454.90% | 9.92% | -71.67% | -52.50% |
| Net Property, Plant & Equipment | 12.38% | 24.93% | 16.34% | 11.35% | -24.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -74.18% | -74.19% | -74.19% | -0.16% | -0.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.14% | 9.54% | 10.54% | 8.06% | 11.53% |
| Total Assets | -32.39% | -14.95% | -53.16% | -13.94% | -14.64% |
|
|
|||||
| Total Accounts Payable | 21.50% | 150.99% | 139.14% | -23.24% | 20.11% |
| Total Accrued Expenses | 12.20% | 29.95% | 7.96% | 9.36% | -19.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 49.66% | 71.01% | 94.74% | 78.19% | 39.62% |
| Total Finance Division Other Current Liabilities | -70.22% | -81.29% | -90.33% | 16.51% | -9.54% |
| Total Other Current Liabilities | -70.22% | -81.29% | -90.33% | 16.51% | -9.54% |
| Total Current Liabilities | -7.59% | 16.28% | 1.13% | 13.16% | -6.12% |
|
|
|||||
| Total Current Liabilities | -7.59% | 16.28% | 1.13% | 13.16% | -6.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.48% | -17.50% | 7.49% | 15.04% | 10.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.96% | -11.17% | -5.49% | 69.62% | 44.70% |
| Total Liabilities | -4.99% | -7.24% | -3.94% | 54.74% | 32.65% |
|
|
|||||
| Common Stock & APIC | 12.80% | 18.30% | 9.01% | 5.38% | 5.38% |
| Retained Earnings | -20.89% | -19.47% | -20.93% | -16.36% | -14.12% |
| Treasury Stock & Other | 129.73% | 2.50% | -57.14% | 78.13% | -9.76% |
| Total Common Equity | -95.16% | -11.82% | -159.97% | -74.15% | -47.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -95.16% | -11.82% | -159.97% | -74.15% | -47.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -95.16% | -39.61% | -147.96% | -77.14% | -53.02% |
|
|
|||||